# US 2010/0167960 A1 · Methods and apparatus for screening and detecting multiple genetic mutations

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2010/0167960 A1
- Document ID: US20100167960A1
- Status: Published application
- Kind: A1
- Application number: 12/574,875
- Filed: 2009-10-07
- Published: 2010-07-01
- Earliest claimed: 2002-07-26
- Assignees: Gamida for Life B.V.
- Inventors: Ray R. Radtkey; Lance C. Held; Robert B. Wallace; Karen Menge; David Canter
- Web page: https://patentgrep.com/patent/US20100167960A1

## CPC

- C12Q 1/6827: for detection of mutation or polymorphism
- C12Q 1/6837: using probe arrays or probe chips (C12Q1/6874 takes precedence)
- Y10T 436/143333: Saccharide [e.g., DNA, etc.]
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- Y10T: TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION

## Abstract

An assay system and methods are described where patient samples containing genomic DNA are analyzed for the presence of known genetic polymorphisms using a universal reporter strategy. In a preferred embodiment, the amplified DNA is localized at test sites in an array of sites on a microchip followed by a series of hybridization reactions that screen for the presence of a single mutation from among a number of mutations, and allow the identification of specific mutations. In addition to universal reporters, the assay may use blockers and discriminators for screening and identification of known polymorphisms.

## Claims

### Claim at position 1

1-40. (canceled)

### Claim 41

A system for detecting members of a set of polymorphisms that occur at identified loci in samples of patient nucleic acid comprising:
loading nucleic acid from the identified loci at at least one addressable site of a microarray;
providing mutant discriminator probes comprising oligonucleotides selective for a member of the set of known polymorphisms and having a first common nucleotide sequence;
providing a universal reporter comprising a label and a nucleotide sequence complementary to the first common nucleotide sequence of the mutant discriminator probe.

### Claim 42

A kit for use in a process of detecting members of a set of polymorphisms that occur at identified loci in samples of patient nucleic acid, said kit comprising:
at least one blocker capable of binding with at least one loci contained in the patient sample nucleic acid;
at least one discriminator capable of binding with at least one loci contained in the patient sample nucleic acid; and
at least one universal reporter capable of binding with the at least one discriminator.

### Claim 43 (depends on 42)

The kit of claim 42, further comprising at least one amplification control being capable of binding with the patient nucleic acid.

### Claim 44 (depends on 43)

The kit of claim 43, further comprising an additional universal reporter capable of binding with the at least one amplification control.

### Claim 45 (depends on 41)

The system of claim 41, wherein the addressable site is a site of an actively addressable electronic microarray.

### Claim 46 (depends on 41)

The system of claim 41, further comprising the step of providing unlabeled oligonucleotides that are complementary to at least one of the identified loci.

### Claim 47 (depends on 41)

The system of claim 41, further comprising the step of detecting the presence of the universal reporter.

### Claim 48 (depends on 41)

The system of claim 41, wherein the nucleic acid from the identified loci comprises multiple segments containing different loci.

### Claim 49 (depends on 48)

The system of claim 48, wherein the multiple segments containing different loci are affixed to the same addressable site of the microarray.

### Claim 50 (depends on 42)

The kit of claim 42, further comprising an actively addressable electronic microarray capable of being loaded with patient sample nucleic acid at individually addressable sites.

### Claim 51 (depends on 42)

The kit of claim 42, wherein the blocker and the discriminator comprise oligonucleotides that are complementary to the at least one loci contained in the patient sample nucleic acid.

### Claim 52 (depends on 51)

The kit of claim 51, wherein the universal reporter comprises a nucleotide sequence that is complementary to the oligonucleotide of the discriminator.

### Claim 53 (depends on 42)

The kit of claim 42, wherein the blocker and the discriminator are capable of binding to different loci contained in the patient sample nucleic acid.
